Related references
Note: Only part of the references are listed.Epigallocatechin-3-gallate mouthwash protects mucosa from radiation-induced mucositis in head and neck cancer patients: a prospective, non-randomised, phase 1 trial
Wanqi Zhu et al.
INVESTIGATIONAL NEW DRUGS (2020)
Bioavailability enhancement of EGCG by structural modification and nano-delivery: A review
Wenzhong Dai et al.
JOURNAL OF FUNCTIONAL FOODS (2020)
Anticancer effects of epigallocatechin-3-gallate nanoemulsion on lung cancer cells through the activation of AMP-activated protein kinase signaling pathway
Bing-Huei Chen et al.
SCIENTIFIC REPORTS (2020)
Epigallocatechin gallate in combination with eugenol or amarogentin shows synergistic chemotherapeutic potential in cervical cancer cell line
Debolina Pal et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Epigallocatechin-3-gallate inhibits the growth and increases the apoptosis of human thyroid carcinoma cells through suppression of EGFR/RAS/RAF/MEK/ERK signaling pathway
Dongdong Wu et al.
CANCER CELL INTERNATIONAL (2019)
Garlic and its Active Compounds: A Potential Candidate in the Prevention of Cancer by Modulating Various Cell Signalling Pathways
Saleh A. Almatroodi et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)
Enoxacin and Epigallocatechin Gallate (EGCG) Act Synergistically to Inhibit the Growth of Cervical Cancer Cells in Culture
Anna Margaret McDonnell et al.
MOLECULES (2019)
The therapeutic potential of epigallocatechin-3-gallate against human oral squamous cell carcinoma through inhibition of cell proliferation and induction of apoptosis: In vitro and in vivo murine xenograft study
Hitoshi Yoshimura et al.
MOLECULAR MEDICINE REPORTS (2019)
Thermal cycling-hyperthermia in combination with polyphenols, epigallocatechin gallate and chlorogenic acid, exerts synergistic anticancer effect against human pancreatic cancer PANC-1 cells
Chueh-Hsuan Lu et al.
PLOS ONE (2019)
Emodin: Its role in prostate cancer-associated inflammation
Yanjie Tu et al.
ONCOLOGY REPORTS (2019)
Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial-Mesenchymal Transition: Enhanced Efficacy When Combined with Gemcitabine
Ran Wei et al.
NUTRIENTS (2019)
Epigallocatechin-3-Gallate (EGCG), An Active Constituent of Green Tea: Implications in the Prevention of Liver Injury Induced by Diethylnitrosamine (DEN) in Rats
Saleh A. Almatroodi et al.
APPLIED SCIENCES-BASEL (2019)
Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts
Ran Wei et al.
CANCERS (2019)
Ginger: A Novel Strategy to Battle Cancer through Modulating Cell Signalling Pathways
Ahmad Almatroudi et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2019)
Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25
Lingling Zan et al.
BIOENGINEERED (2019)
Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-beta 1/Smad signaling pathways
Tingting Li et al.
BIOENGINEERED (2019)
Epigallocatechin-3-Gallate Suppresses Human Herpesvirus 8 Replication and Induces ROS Leading to Apoptosis and Autophagy in Primary Effusion Lymphoma Cells
Ching-Yi Tsai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells
Veronika Borutinskaite et al.
LEUKEMIA & LYMPHOMA (2018)
Epigallocatechin-3-gallate enhances differentiation of acute promyelocytic leukemia cells via inhibition of PML-RAR and HDAC1
Maliheh Moradzadeh et al.
PHYTOTHERAPY RESEARCH (2018)
A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer
Jianzhang Wang et al.
CANCER LETTERS (2018)
Nanoemulsion delivery system of tea polyphenols enhanced the bioavailability of catechins in rats
Yunru Peng et al.
FOOD CHEMISTRY (2018)
SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition
Wanchun Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways
Liang Cheng et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Preparation of chitosan-Epigallocatechin-3-O-gallate nanoparticles and their inhibitory effect on the growth of breast cancer cells
Yingyi Liu et al.
JOURNAL OF INNOVATIVE OPTICAL HEALTH SCIENCES (2018)
Epigallocatechin-3-gallate inhibited cancer stem cell-like properties by targeting hsa-mir-485-5p/RXRα in lung cancer
Pan Jiang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Bioavailability of Tea Catechins and Its Improvement
Zhuo-Yu Cai et al.
MOLECULES (2018)
Suppressive Effects of EGCG on Cervical Cancer
Ying-Qi Wang et al.
MOLECULES (2018)
Achievable Central Nervous System Concentrations of the Green Tea Catechin EGCG Induce Stress in Glioblastoma Cells in Vitro
Susanne Grube et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2018)
Enhanced oral bioavailability of EGCG using pH-sensitive polymeric nanoparticles: characterization and in vivo investigation on nephrotic syndrome rats
Guojuan Zhang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models
Ran Wei et al.
FOOD & FUNCTION (2018)
Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling
Chien-Han Yuan et al.
ENVIRONMENTAL TOXICOLOGY (2017)
Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
Tae Won Kwak et al.
ONCOTARGETS AND THERAPY (2017)
Metformin Sensitizes Non-small Cell Lung Cancer Cells to an Epigallocatechin-3-Gallate (EGCG) Treatment by Suppressing the Nrf2/HO-1 Signaling Pathway
Chenxiao Yu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Natural Compounds from Herbs that can Potentially Execute as Autophagy Inducers for Cancer Therapy
Shian-Ren Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN
Shifei Yao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Polymeric nanoparticles: Promising platform for drug delivery
Khalid M. El-Say et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9
Ke-Wang Luo et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2017)
Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells
Liang Liu et al.
PATHOLOGY RESEARCH AND PRACTICE (2017)
Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase
Maliheh Moradzadeh et al.
PHARMACOLOGICAL REPORTS (2017)
Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice
Xin Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human breast cancer
Chao-You Huang et al.
ONCOLOGY LETTERS (2017)
Epigallocatechin-3-gallate induces apoptosis in acute promyelocytic leukemia cells via a SHP-1-p38α MAPK-Bax cascade
Liugen Gan et al.
ONCOLOGY LETTERS (2017)
Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and downregulation of MDR-1 and P-gp expression in gastric cancer
Hongsheng Tang et al.
ONCOTARGET (2017)
Combination curcumin and (-)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway
G. Jin et al.
ONCOGENESIS (2017)
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
Munawar A. Mohammed et al.
PHARMACEUTICS (2017)
Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy
Vanna Sanna et al.
SCIENTIFIC REPORTS (2017)
Physiologically based pharmacokinetic modeling of tea catechin mixture in rats and humans
Francis C. P. Law et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2017)
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers
Jason R. Gee et al.
CANCER PREVENTION RESEARCH (2017)
Wnt/β-catenin pathway mediates (-)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells
Jianyun Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1
Kewei Zhu et al.
TUMOR BIOLOGY (2016)
Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy
Hanxi Zhao et al.
BRITISH JOURNAL OF RADIOLOGY (2016)
Inhibition of green tea polyphenol EGCG((-)-epigallocatechin-3-gallate) on the proliferation of gastric cancer cells by suppressing canonical wnt/β-catenin signalling pathway
Chenggang Yang et al.
INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION (2016)
Fabrication of BSA-Green Tea Polyphenols-Chitosan Nanoparticles and Their Role in Radioprotection: A Molecular and Biochemical Approach
Sumit Kumar et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2016)
Tea polyphenols epigallocatechin gallete and theaflavin restrict mouse liver carcinogenesis through modulation of self-renewal Wnt and hedgehog pathways
Subhayan Sur et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2016)
Estrogen receptor-α36 is involved in epigallocatechin-3-gallate induced growth inhibition of ER-negative breast cancer stem/progenitor cells
Xiaohua Pan et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2016)
(-)-Epigallocatechin-3-gallate induces apoptosis in human pancreatic cancer cells via PTEN
Shi Liu et al.
MOLECULAR MEDICINE REPORTS (2016)
EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation
Min Li et al.
ONCOLOGY REPORTS (2016)
Anti-cancer effect of (-)-epigallocatechin-3-gallate (EGCG) in head and neck cancer through repression of transactivation and enhanced degradation of β-catenin
Yoo Seob Shin et al.
PHYTOMEDICINE (2016)
Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9
Shao-Jun Chen et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins
Nagi B. Kumar et al.
ONCOTARGET (2016)
In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity
Sainan Li et al.
SCIENTIFIC REPORTS (2016)
Combination of erlotinib and EGCG induces apoptosis of head and neck cancers through posttranscriptional regulation of Bim and Bcl-2
Abedul Haque et al.
APOPTOSIS (2015)
Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells
Dae-Woon Eom et al.
BMB REPORTS (2015)
The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells
Christian Mayr et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention
Nagi B. Kumar et al.
CANCER PREVENTION RESEARCH (2015)
(-)-Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase-dependent pathway and Bcl-2 family protein modulation
Jiangyan Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells
Fen Hu et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
(-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells
Munawwar Ali Khan et al.
ONCOLOGY REPORTS (2015)
Inhibitory effect of (-)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth
Sabrina Bimonte et al.
INFECTIOUS AGENTS AND CANCER (2015)
Epigallocatechin-3-gallate induces the apoptosis of hepatocellular carcinoma LM6 cells but not non-cancerous liver cells
Yunjuan Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Metabolic consequences of LDHA inhibition by epigallocatechin gallate and oxamate in MIA PaCa-2 pancreatic cancer cells
Qing-Yi Lu et al.
METABOLOMICS (2015)
Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo
Lifeng Liu et al.
ONCOLOGY REPORTS (2015)
Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model
Naghma Khan et al.
CARCINOGENESIS (2014)
Green Tea Polyphenol Epigallocatechin-3-Gallate Inhibits TNF-α-Induced Production of Monocyte Chemoattractant Protein-1 in Human Umbilical Vein Endothelial Cells
Ze-Mu Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Therapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways
Arshad H. Rahmani et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate
Sabita N. Saldanha et al.
EXPERIMENTAL CELL RESEARCH (2014)
Improved in vitro digestion stability of (-)-epigallocatechin gallate through nanoliposome encapsulation
Li-qiang Zou et al.
FOOD RESEARCH INTERNATIONAL (2014)
Lipase-catalyzed synthesis of acetylated EGCG and antioxidant properties of the acetylated derivatives
Song Zhu et al.
FOOD RESEARCH INTERNATIONAL (2014)
Epigallocatechin-3-gallate prevents tumor cell implantation/growth in an experimental rat bladder tumor model
Jerzy Jankun et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Antiproliferative activity of tea catechins associated with casein micelles, using HT29 colon cancer cells
S. Haratifar et al.
JOURNAL OF DAIRY SCIENCE (2014)
Chemopreventive and hepatoprotective effects of Epigallocatechin-gallate against hepatocellular carcinoma: role of heparan sulfate proteoglycans pathway
Mohamed M. Darweish et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2014)
Reversal of Cisplatin Resistance by Epigallocatechin Gallate Is Mediated by Downregulation of Axl and Tyro 3 Expression in Human Lung Cancer Cells
Kyung-Chan Kim et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2014)
Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway
Yu-Chao Ma et al.
ONCOLOGY REPORTS (2014)
Quercetin and EGCG Exhibit Chemopreventive Effects in Cholangiocarcinoma Cells via Suppression of JAK/STAT Signaling Pathway
Laddawan Senggunprai et al.
PHYTOTHERAPY RESEARCH (2014)
Synergistic Apoptosis-Inducing Effects on A375 Human Melanoma Cells of Natural Borneol and Curcumin
Jianping Chen et al.
PLOS ONE (2014)
A phase I study of concurrent chemotherapy and thoracic radiotherapy with oral epigallocatechin-3-gallate protection in patients with locally advanced stage III non-small-cell lung cancer
Hanxi Zhao et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate
Liangdong Jiang et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2014)
Epigallocatechin-3-gallate induces apoptosis, inhibits proliferation and decreases invasion of glioma cell
Hong Li et al.
NEUROSCIENCE BULLETIN (2014)
Curcumin: A Potential Candidate in Prevention of Cancer via Modulation of Molecular Pathways
Arshad H. Rahmani et al.
BIOMED RESEARCH INTERNATIONAL (2014)
PI3K/AKT/mTOR Signaling is Involved in (-)-Epigallocatechin-3-Gallate-Induced Apoptosis of Human Pancreatic Carcinoma Cells
Shi Liu et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2013)
Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3′-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways
Ying Gao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Induction of the Connexin 32 Gene by Epigallocatechin-3-Gallate Potentiates Vinblastine-Induced Cytotoxicity in Human Renal Carcinoma Cells
Ayami Sato et al.
CHEMOTHERAPY (2013)
Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway
Sang Hyuk Lee et al.
EUROPEAN JOURNAL OF CANCER (2013)
Synergistic Anticancer Effects of Vorinostat and Epigallocatechin-3-Gallate against HuCC-T1 Human Cholangiocarcinoma Cells
Tae Won Kwak et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation
Huaping Chen et al.
EXPERIMENTAL CELL RESEARCH (2013)
A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer
Dominique Trudel et al.
GYNECOLOGIC ONCOLOGY (2013)
Regulation of Id1 expression by epigallocatechin-3-gallate and its effect on the proliferation and apoptosis of poorly differentiated AGS gastric cancer cells
Jun Ma et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Nanoencapsulation Enhances Epigallocatechin-3-gallate Stability and Its Antiatherogenic Bioactivities in Macrophages
Jia Zhang et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2013)
Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines
Francesca De Amicis et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
(-)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation
Murli Manohar et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Protective effects of (-)-epigallocatechin-3-gallate against TNF-α-induced lung inflammation via ROS-dependent ICAM-1 inhibition
I-Ta Lee et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2013)
Mechanism of the inhibition of the STAT3 signaling pathway by EGCG
Yang Wang et al.
ONCOLOGY REPORTS (2013)
Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells
Longyu Jin et al.
ONCOLOGY REPORTS (2013)
Inhibitory effect of Epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression
Chunxiao Yan et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
(-)-Epigallocatechin-3-gallate, a green tea-derived catechin, synergizes with celecoxib to inhibit IL-1-induced tumorigenic mediators by human pancreatic adenocarcinoma cells Colo357
Carmen Haerdtner et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Antiproliferative and apoptotic effect of epigallocatechin-3-gallate on Ishikawa cells is accompanied by sex steroid receptor downregulation
Seung Bin Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity
Yoo-Hyun Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Combined administration of EGCG and IL-1 receptor antagonist efficiently downregulates IL-1-induced tumorigenic factors in U-2 OS human osteosarcoma cells
Anne-Sophie Hoenicke et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells
Oana Tudoran et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin
Fei Ye et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Green tea polyphenol epigallocatechin-3-gallate suppresses melanoma growth by inhibiting inflammasome and IL-1β secretion
Lixia Z. Ellis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles
Dar-Shih Hsieh et al.
BIOMATERIALS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy
Michael Frezza et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
(-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression
Chihiro Onoda et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Epigallocatechin-3 Gallate Inhibits Invasion, Epithelial-Mesenchymal Transition, and Tumor Growth in Oral Cancer Cells
Pei-Ni Chen et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2011)
Green tea (-)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met
Yoon Woo Koh et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: Roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways
Nian-Gu Chen et al.
ONCOLOGY REPORTS (2011)
The chemistry and biotransformation of tea constituents
Shengmin Sang et al.
PHARMACOLOGICAL RESEARCH (2011)
Synergistic Effects of the Green Tea Extract Epigallocatechin-3-gallate and Taxane in Eradication of Malignant Human Prostate Tumors
Mark E. Stearns et al.
TRANSLATIONAL ONCOLOGY (2011)
Combination Therapy with Epigallocatechin-3-Gallate and Doxorubicin in Human Prostate Tumor Modeling Studies Inhibition of Metastatic Tumor Growth in Severe Combined Immunodeficiency Mice
Mark E. Stearns et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate
Admire Dube et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Green tea: A promising anticancer agent for renal cell carcinoma
Marcia Carvalho et al.
FOOD CHEMISTRY (2010)
Effective use of reducing agents and nanoparticle encapsulation in stabilizing catechins in alkaline solution
Admire Dube et al.
FOOD CHEMISTRY (2010)
Indoleamine 2,3-Dioxygenase, an Immunomodulatory Protein, Is Suppressed by (-)-Epigallocatechin-3-gallate via Blocking of γ-Interferon-Induced JAK-PKC-δ-STAT1 Signaling in Human Oral Cancer Cells
Chieh-Wen Cheng et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
Antihypertensive Effect of Benifuuki Tea Containing O-Methylated EGCG
Ikuko Kurita et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
Anti-Melanoma Effects of Vorinostat in Combination with Polyphenolic Antioxidant (-)-Epigallocatechin-3-Gallate (EGCG)
Minakshi Nihal et al.
PHARMACEUTICAL RESEARCH (2010)
Potentiation of (-)-epigallocatechin-3-gallate-induced apoptosis by bortezomib in multiple myeloma cells
Qing Wang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2009)
Green Tea Catechin Controls Apoptosis in Colon Cancer Cells by Attenuation of H2O2-Stimulated COX-2 Expression via the AMPK Signaling Pathway at Low-Dose H2O2
In-Ja Park et al.
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)
Difference in growth suppression and apoptosis induction of EGCG and EGC on human promyelocytic leukemia HL-60 cells
Dong Hoon Han et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
Synergistic Growth Inhibition of Squamous Cell Carcinoma of the Head and Neck by Erlotinib and Epigallocatechin-3-Gallate: The Role of p53-Dependent Inhibition of Nuclear Factor-κB
A. R. M. Ruhul Amin et al.
CANCER PREVENTION RESEARCH (2009)
(-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells
Seiji Adachi et al.
CARCINOGENESIS (2009)
(-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma
Minakshi Nihal et al.
CELL CYCLE (2009)
Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells
Molly Lang et al.
LIVER INTERNATIONAL (2009)
A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate
M. J. Scandlyn et al.
BRITISH JOURNAL OF CANCER (2008)
Oxidative stress, DNA methylation and carcinogenesis
Rodrigo Franco et al.
CANCER LETTERS (2008)
Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation
Daniel S. Albrecht et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2008)
Inhibition of invasion and up-regulation of E-cadherin expression in human malignant melanoma cell line A375 by (-)-epigallocatechin-3-gallate
Yan Wu et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2008)
Green tea extract, epigallocatechin-3-gallate, inhibits the growth and invasive ability of human glioma cells
Wei Zhang et al.
MOLECULAR MEDICINE REPORTS (2008)
Epigalocatechin-3-gallate (EGCG) downregulates PEA15 and thereby augments TRAIL-mediated apoptosis in malignant glioma
M. D. Siegelin et al.
NEUROSCIENCE LETTERS (2008)
Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells
Sujit Nair et al.
PHARMACEUTICAL RESEARCH (2008)
The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells
Kimberly M. Rieger-Christ et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer
Sharmila Shankar et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis
Bao-He Zhu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution
Lei-Chwen Lin et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
Inhibition of epigallocatechin gallate on orthotopic colon cancer by upregulating the Nrf2-UGT1A signal pathway in nude mice
Jun-Hua Yuan et al.
PHARMACOLOGY (2007)
Specific killing of multiple myeloma cells by (-)-epigaflocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications
Masood A. Shammas et al.
BLOOD (2006)
Green tea polyphenol stimulates cancer preventive effects of celecoxib in human lung cancer cells by upregulation of GADD153 gene
Masami Suganuma et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma
Francesca Spinella et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Epigallocatechin gallate reduces hypoxia-induced apoptosis in human hepatoma cells
Hae Jeong Park et al.
LIFE SCIENCES (2006)
Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas
Jia-You Fang et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2006)
Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility
MM Chan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals
HHS Chow et al.
CLINICAL CANCER RESEARCH (2005)
(-)-epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells
M Shimizu et al.
CLINICAL CANCER RESEARCH (2005)
Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells
T Hussain et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Inhibition of the vascular-endothelial growth factor-induced intracellular signaling and mitogenesis of human endothelial cells by epigallocatechin-3 gallate
T Neuhaus et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells
K Chisholm et al.
ANTI-CANCER DRUGS (2004)
Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines
SW Huh et al.
GYNECOLOGIC ONCOLOGY (2004)
Bioavailability of dietary doses of 3H-labelled tea antioxidants (+)-catechin and (-)-epicatechin in rat
F Catterall et al.
XENOBIOTICA (2003)
Tea catechin synergies in inhibition of cancer cell, proliferation and of a cancer specific cell surface oxidase (ECTO-NOX)
DJ Morré et al.
PHARMACOLOGY & TOXICOLOGY (2003)
A single ascending dose study of epigallocatechin gallate in healthy volunteers
U Ullmann et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2003)
Intestinal uptake of quercetin-3-glucoside in rats involves hydrolysis by lactase phlorizin hydrolase
ALA Sesink et al.
JOURNAL OF NUTRITION (2003)
Molecular pathway for (-)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells
S Gupta et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2003)
Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells
MR Sartippour et al.
JOURNAL OF NUTRITION (2002)
Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate
N Ahmad et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress
SK Katiyar et al.
CARCINOGENESIS (2001)
Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice
JD Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice
M Suganuma et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2001)
Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death
C Chen et al.
ARCHIVES OF PHARMACAL RESEARCH (2000)
Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion
C Li et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2000)
Antioxidant properties of (-)-epicatechin-3-gallate and its inhibition of Cr(VI)-induced DNA damage and Cr(IV)- or TPA-stimulated NF-kappa B activation
XL Shi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2000)
Chemoprotection against cancer by induction of Phase 2 enzymes
P Talalay
BIOFACTORS (2000)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
Share Paper
